RPS11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.252400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.946000E-01
Normal-vs-Stage2
5.877800E-01
Normal-vs-Stage3
7.673000E-01
Normal-vs-Stage4
5.475000E-01
Stage1-vs-Stage2
8.730800E-01
Stage1-vs-Stage3
9.681600E-01
Stage1-vs-Stage4
1.957200E-01
Stage2-vs-Stage3
9.464400E-01
Stage2-vs-Stage4
3.077200E-01
Stage3-vs-Stage4
3.814600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.138000E-01
Normal-vs-AfricanAmerican
4.685000E-01
Normal-vs-Asian
9.252400E-01
Caucasian-vs-AfricanAmerican
3.245800E-01
Caucasian-vs-Asian
7.960600E-01
AfricanAmerican-vs-Asian
4.034600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.467800E-01
Normal-vs-Female
4.502800E-01
Male-vs-Female
2.784600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.709600E-01
Normal-vs-Age(41-60Yrs)
3.162000E-01
Normal-vs-Age(61-80Yrs)
7.324600E-01
Normal-vs-Age(81-100Yrs)
9.243400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.372400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.120000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.165600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.080240E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.846500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.959800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.269600E-01
Normal-vs-Daily Drinker
9.425200E-01
Normal-vs-Weekly Drinker
8.868600E-01
Normal-vs-Occasional Drinker
8.257800E-01
Normal-vs-Social Drinker
1.699990E-01
Non Drinker-vs-Daily Drinker
1.510050E-01
Non Drinker-vs-Weekly Drinker
5.126600E-01
Non Drinker-vs-Occasional Drinker
1.733590E-01
Non Drinker-vs-Social Drinker
4.870800E-01
Daily Drinker-vs-Weekly Drinker
8.322600E-01
Daily Drinker-vs-Occasional Drinker
8.440600E-01
Daily Drinker-vs-Social Drinker
4.088000E-02
Weekly Drinker-vs-Occasional Drinker
9.370200E-01
Weekly Drinker-vs-Social Drinker
2.988800E-01
Occasional Drinker-vs-Social Drinker
2.796000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.047400E-01
Normal-vs-Grade 2
3.612400E-01
Normal-vs-Grade 3
4.375600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.936000E-01
Grade 1-vs-Grade 3
8.368800E-01
Grade 1-vs-Grade 4
5.047400E-01
Grade 2-vs-Grade 3
5.367600E-01
Grade 2-vs-Grade 4
3.612400E-01
Grade 3-vs-Grade 4
4.375600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.901800E-01
Normal-vs-NonDiabetic
6.119600E-01
Diabetic-vs-NonDiabetic
7.887000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.874800E-01
Normal-vs-NoPancreatitis
6.555400E-01
Pancreatitis-vs-NoPancreatitis
5.294800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.000800E-01
Normal-vs-N1
5.727400E-01
N0-vs-N1
2.737200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.498800E-01
Normal-vs-TP53-NonMutant
6.138200E-01
TP53-Mutant-vs-TP53-NonMutant
3.882200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
